Skip to content

Glaukos GKOS Total Equity

Total Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$31.42B+6.9%
AbbVie logo
AbbVieABBV
-$6.66B-569%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$8.24B-0.6%
Exelixis logo
ExelixisEXEL
$1.94B-9.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's total equity?
Glaukos (GKOS) reported total equity of $670.93M in Q1 2026.
How has Glaukos's total equity changed year-over-year?
Glaukos's total equity decreased by 12.2% year-over-year, from $763.96M to $670.93M.
What is the long-term trend for Glaukos's total equity?
Over 5 years (2020 to 2025), Glaukos's total equity has grown at a -0.3% compound annual growth rate (CAGR), from $667.45M to $656.16M.
What does total equity mean?
The net value of the company belonging to shareholders after all debts are paid.
How do you interpret total equity?
A growing equity base generally signals strong financial health and value creation for shareholders.
How does total equity compare across companies?
Varies by industry; essential for calculating Return on Equity (ROE) across all sectors.